Translations:SGLT2 inhibitor/43/ja: Difference between revisions
Created page with "==外部リンク== * {{cite web | title=FDA revises label of diabetes drug canagliflozin | website=U.S. Food and Drug Administration | date=15 January 2016 | url=https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-revises-label-diabetes-drug-canagliflozin-invokana-invokamet }} * {{cite web | title=FDA Drug Safety Communication: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana,..." |
(No difference)
|